Aisel’s €1.7M Builds Psychiatry OS Beyond Note Writing

Aisel Health closed a €1.7 million pre-seed round led by Caesar Ventures to scale its psychiatry-specific operating system across private clinics and into the UK. The Copenhagen company, founded in 2024 by Augusta Klingsten Peytz and Christian Houen, argues that faster notes alone leave the real capacity bottleneck untouched.

Investors joining Caesar include Nordic Web Ventures, LifeX, Angel Invest and returning backers Rockstart and EIFO. The capital grows the clinical and engineering teams while converting an active private-psychiatry pipeline ahead of a planned seed.

The Round and the Founders Behind It

Carolin Gabor, managing partner and GP at Caesar Ventures, said few healthcare problems are as large or overlooked as psychiatry’s, and few founders match the passion of Augusta and Christian. Peytz, co-founder and CEO, has a background in business and consulting shaped by personal experience with mental health challenges. Houen serves as co-founder and chief product officer.

The company states it already works with psychiatrists across Northern Europe. Its public materials list a clinical team that includes Lotte Kjær Svalberg as clinical product manager and several medical advisers. Data stays on EU/UK servers under GDPR rules; Aisel says it never trains models on patient records and does not hold the records themselves.

• Lead: Caesar Ventures
• Participants: Nordic Web Ventures, LifeX, Angel Invest
• Existing: Rockstart, EIFO
• Use of funds: clinical and engineering hires plus UK entry

Peytz framed the need plainly in the announcement: psychiatry does not need more generic technology bolted onto an overburdened workflow. It needs a product built around the realities of psychiatric care, where clinicians bring judgment and the technology holds every detail no human memory can.

Why Faster Notes Still Leave Lists Long

AI medical scribes dominate conference floors and promise relief from evening paperwork. Houen grants they work for immediate burnout. Notes get written faster. That is useful.

Yet he argues the same cheap notes create a new problem. Information piles up across referrals, prior visits and multiple systems. When the patient returns, the clinician still faces too much text and too little time to read it. Patients repeat themselves. Details get missed. Compliance is satisfied; understanding is not.

“Make notes cheaper to produce, and you just make that information harder for a clinician to find when they need it,” Houen said. “We still have yet to overcome the human limitation of understanding everything that was ever written about every patient ever treated. That’s the problem we built Aisel to solve: giving clinicians exactly what they need, when, and how they need it.”

According to the company, clinicians spend only around 40 percent of their time with patients. The rest goes to gathering, reading, writing and admin. Shortening the writing step alone does not open new appointment slots if prep and handoffs still consume the day.

Where the Minutes Go

Aisel’s own research paper, The Documentation Minute, timed 202 documentation tasks across eight clinics in Denmark and the UK. Sixteen document types appear. The longest sit at the top of the chart and almost never appear in AI-scribe studies.

The paper is open about its limits. Assisted times come from stopwatch data at one site; most unassisted times are retrospective estimates from other clinics. It is observational, not a randomised trial, and Aisel develops one of the tools under study. Still, the map is clear: the heavy statutory and medico-legal reports take three to four times longer than a standard note, and the published AI literature has barely touched them.

Author Lotte Kjær Svalberg notes that of 23 studies in the most recent systematic review, 20 evaluated only the post-consultation note. The reports at the top of the chart appeared in none.

• 62% mean reduction on clinical notes (14.5 to 5.5 minutes)
• ~40% of clinician time spent face-to-face with patients
• 57.1 minutes average for a Mental Health Act report
• Next study targets the long-form reports with AI assistance

A Sphere of Understanding That Travels With the Patient

Aisel describes a “sphere of understanding” that grows around each patient as interviews, documents and external accounts accumulate. Psychiatric protocols and a fact-deduction layer surface the pieces relevant to the next decision, with sources and citations attached. The clinician reviews and confirms rather than hunting.

These questions are formative to treatment, so they need to be asked. If clinicians don’t have access to that information upfront, or it’s buried somewhere in the documents, they’ll simply ask again because then they know they’re compliant and have the information.

Christian Houen, Co-Founder and Chief Product Officer, Aisel Health

That matters when a patient moves from GP to psychiatrist, or between providers, or even when the same clinician sees the case weeks later after a hundred others. Continuity no longer depends solely on human recall or a hurried chart review minutes before the door opens.

For ADHD and child assessments the platform can send adaptive AI interviews to relatives, schools and other parties so everyone feeds the same shared record. Houen says the company is piloting this with a children’s clinic. Previously staff had to phone each contact, chase non-responders and collate answers by hand. That coordination alone stretches child and youth psychiatry waits.

Early validation ran the system in parallel with existing processes and used blind clinician comparisons of the resulting reports. Focus has shifted toward response rates, clinician satisfaction and patient scores that are fed back so teams can adjust what patients find hard.

From Patient Context to Full Clinic Operations

The product vision reaches past the individual consult. Aisel positions itself as an operating layer. Many tasks around the patient can be deduced from conversation context and surfaced to the right person inside the clinic.

Rebooking is the simple example Houen gives. Doctor and patient agree on a follow-up. The secretary never hears. The patient assumes it is arranged. Weeks later the next free slot is six weeks out. The platform aims to close that loop automatically.

On the company site the workflow is described as six AI agents for intake through EHR sync: adaptive screening that responds to answers in real time, structured clinical data extraction, context-aware listening during the session, notes that preserve the clinician’s voice, billing codes derived from content for confirmation, and bidirectional EHR updates.

Heavy documents such as court reports, Mental Health Act work and benefits certificates get citation of every statement back to source records, contradiction flags and checks against required content. The clinician still authors and signs; the system prepares and verifies.

Security claims match institutional expectations: end-to-end encryption, data residency in the UK and EU, full clinic control of its own data.

UK Entry and the Capacity Bet

Private psychiatry is the near-term commercial focus. An active pipeline sits ready for conversion. Public systems face steeper scale and procurement hurdles, yet the same time sinks exist. In England the BMA’s latest estimates put the mental health waiting list at 1.7 million people. Some patients on the longest community waits have waited nearly two years.

Aisel’s mission to cut waiting times in psychiatry rests on giving time back at every friction point: prep before the session, continuity across handoffs, external information gathering, and the admin that currently falls between roles. If those minutes convert into extra appointments, lists shorten. The company does not yet publish a controlled measure of additional slots opened; that remains the open test for the next stage of evidence.

The pre-seed buys the team and market entry needed to run that test at larger volume. A seed round is already on the calendar. Psychiatry’s capacity crisis has been decades in the making. One specialised operating system will not erase it. The bet is that owning the full loop of understanding and operations moves the needle farther than another general scribe ever will.

Frequently Asked Questions

What does Aisel Health’s psychiatry operating system actually do?

It turns interview recordings, existing documents and multi-party accounts into structured, cited insights that surface at the moment a clinician needs them, before, during and after a consultation, while also handling derived admin tasks such as booking cues and billing codes. The six agents cover adaptive intake, data structuring, session listening, voice-matched documentation, code suggestion and EHR synchronisation, all designed around psychiatric protocols rather than generic medical templates.

Who founded Aisel Health and when?

Augusta Klingsten Peytz (CEO) and Christian Houen (CPO) founded the Copenhagen company in 2024. The clinical team includes practising psychiatrists and psychologists across Northern Europe who help shape the workflows.

What did The Documentation Minute research find about psychiatrist time?

Across 202 timed tasks in eight Danish and UK clinics, standard clinical notes averaged 14.5 minutes unassisted and 5.5 minutes with Aisel assistance, a 62 percent mean reduction. Longer statutory documents such as Mental Health Act reports averaged 57.1 minutes and have rarely been studied with AI tools at all. The paper itself flags its observational design and author conflict of interest.

How does Aisel differ from ordinary AI medical scribes?

Scribes primarily accelerate note writing after or during a visit. Aisel treats the accumulated record as a retrieval and continuity problem: it builds a growing patient sphere, cites sources, flags contradictions on heavy reports, pulls external informants for child and ADHD cases, and surfaces ops tasks that would otherwise stall between clinician and admin staff.

How will Aisel use the €1.7 million?

The company will expand its clinical and engineering headcount and fund UK market entry by converting its existing commercial pipeline of private psychiatry clinics, positioning itself for a subsequent seed round.

Disclaimer: This article is news reporting and analysis based on company announcements, research publications and public health statistics. It is informational only and does not constitute medical, investment, legal or clinical advice of any kind. Readers considering mental health care, clinic technology purchases or related investments should consult a qualified psychiatrist, clinician, financial adviser or legal professional before taking any action. Figures, product claims and market statuses reflect the cited sources as of August 2026 and may change as new data or commercial results appear.